Roxatidine acetate hydrochloride is a selective histamine H2 receptor antagonist primarily indicated for the clinical treatment of gastric ulcers, erosive esophagitis, gastro-oesophageal reflux disease,… Read more
Roxatidine acetate hydrochloride is a selective histamine H2 receptor antagonist primarily indicated for the clinical treatment of gastric ulcers, erosive esophagitis, gastro-oesophageal reflux disease, gastritis, and Zollinger–Ellison syndrome. Pharmaceutical laboratories utilize this category to access high-quality reference standards of the active pharmaceutical ingredient, alongside its critical pharmacopeial and non-pharmacopeial impurities. These compounds are essential for rigorous impurity profiling, method validation, and routine quality control testing. Furthermore, the inclusion of stable isotope-labelled compounds supports the development and optimization of precise quantitative bioanalytical methods, ensuring accurate detection and quantification of the drug and its metabolites in complex biological matrices. By maintaining strict analytical standards, researchers can reliably monitor drug stability and purity throughout the pharmaceutical development lifecycle and production process.